Skip to content

The Neural Correlates of Cannabis Use

The Neural Correlates of Cannabis Use

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03104257
Acronym
Multimodal
Enrollment
162
Registered
2017-04-07
Start date
2016-12-31
Completion date
2022-04-27
Last updated
2025-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cannabis Dependence, Healthy

Keywords

Healthy Control, Cannabis, Dependence

Brief summary

The purpose of this research study is to determine the temporal course of recovery of CB1R availability and neural oscillations, in cannabis-dependent individuals at baseline, following 48 hour confirmed inpatient abstinence and after four weeks confirmed abstinence. This research will also examine associations between CB1R availability, neural oscillations and cognitive function.

Detailed description

The purpose of this research study is to determine the temporal course of recovery of CB1R availability and neural oscillations, in cannabis-dependent individuals at baseline, following 48 hour confirmed inpatient abstinence and after four weeks confirmed outpatient abstinence (confirmed by tracking creatinine adjusted urine THC-COOH levels). This research will also examine associations between CB1R availability, neural oscillations and cognitive function using \[11-C\]OMAR PET imaging and electroencephalography.

Interventions

The radiotracer, \[11-C\]OMAR will be administered at no more than 10 micrograms at the beginning of each PET scan.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Cannabis Dependent Subjects * Current cannabis consumption * Willing to abstain from cannabis use for four weeks Inclusion Criteria for Healthy Controls * No current cannabis consumption

Exclusion criteria

* MRI metal exclusions and claustrophobia * Education completed is less than 12 years

Design outcomes

Primary

MeasureTime frameDescription
CB1R availability using [11-C]OMAR PET imagingChange in CB1R availability from baseline to 48 hours and 28 daysChange in CB1R availability (e.g. volume distribution).

Secondary

MeasureTime frameDescription
Changes in Cognition during withdrawal using a computerized batteryChange in CB1R availability from baseline to 48 hours and 28 daysChanges in cognitive functions such as attention, memory, motor functioning, and processing speed.
Changes in brain rhythms measured by ElectroencephalographyChange in CB1R availability from baseline to 48 hours and 28 daysChanges in electroencephalographic (EEG) brain rhythms related to information processing.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026